Physician profile
Michelle M Olson
NPI 1366405102
$1,266.59
in general payments reported to CMS, 2019-2025
15 companies · $517 in 2025
The $517 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2021: $29.72 · 2022: $86.59 · 2023: $166 · 2024: $173 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $453.23 | 2023-2025 | Interstim, Signia, Ligasure |
| Biom'Up Sa | $196.12 | 2019 | |
| Hollister Incorporated | $114.87 | 2025 | New Image |
| Olympus America INC. | $97.72 | 2019 | |
| Sirtex Medical INC | $94.24 | 2023 | Sir-Spheres Microspheres |
| Integra Lifesciences Corporation | $54.59 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Abbvie INC. | $51.02 | 2021-2022 | |
| Mimedx Group, INC. | $46.55 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $34.69 | 2022-2023 | |
| Vertex Pharmaceuticals Incorporated | $34.29 | 2024 | |
| Axonics, INC. | $23.79 | 2024 | Axonics |
| Urgo Medical North America, LLC | $19.40 | 2023 | Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Takeda Pharmaceuticals U.S.A., INC. | $17.30 | 2021 | |
| Daiichi Sankyo INC. | $14.98 | 2022 | |
| Qol Medical, LLC | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.